Abstract
Mycobacterium tuberculosis continues to be a major cause of morbidity and mortality in the world. One-third of the world population is estimated to be infected with tuberculosis resulting in 8.8 million new cases and 1.4 million deaths associated to tuberculosis in 2011 (WHO-fact sheet-2011). The emergence of multidrug-resistant (MDR) and other forms of extensive-drug-resistant (XDR) tuberculosis in many parts of the world is threatening to send us back to an era when tuberculosis was an untreatable disease. Despite the fast pace of progress in the field of tuberculosis research in the last decade, the implementation of promising discoveries continues to be a challenge. In most countries, National Tuberculosis Programs are still using smear microscopy, a 120-year-old technology, to diagnose tuberculosis and treatment regimens that have not changed in the past 40 years. Furthermore, we still have important gaps in our knowledge of the basic biology of M. tuberculosis, as it pertains to pathogen and human interactions. We still do not know the extent of genetic diversity in tuberculosis bacteria, nor do we understand the implications of this diversity in terms of virulence, vaccine, and drug development. Nevertheless, there is fascinating new research into the global diversity of tuberculosis strains and its association to ancient human migrations out of Africa, as well as to more recent migration patterns of humans in the last 500 years. These most recent insights into the diversity of tuberculosis and human coevolution are promising a more far-reaching understanding of the biology of tuberculosis with potential payoffs for the eventual elimination of tuberculosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Russell DG (2011) Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol Rev 240(1):252–268
Smith NH, Hewinson RG, Kremer K, Brosch R, Gordon SV (2009) Myths and misconceptions: the origin and evolution of Mycobacterium tuberculosis. Nat Rev Microbiol 7(7):537–544
Iseman MD (2000) A clinician’s guide to tuberculosis, 1st edn. Lippincott Williams & Wilkins, Philadelphia
Blaser MJ, Kirschner D (2007) The equilibria that allow bacterial persistence in human hosts. Nature 449(7164):843–849
Small PM, Fujiwara PI (2001) Management of tuberculosis in the United States. N Engl J Med 345(3):189–200
Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, Kremer K et al (2010) Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 42(6):498–503
Burgos M, DeRiemer K, Small PM, Hopewell PC, Daley CL (2003) Effect of drug resistance on the generation of secondary cases of tuberculosis. J Infect Dis 188(12):1878–1884
Flores L, Kato-Maeda M, Metcalfe JZ (2011) Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol 6(2):203–216
Hanekom M, Gey van Pittius NC, McEvoy C, Victor TC, Van Helden PD, Warren RM (2011) Mycobacterium tuberculosis Beijing genotype: a template for success. Tuberculosis 91(6):510–523
Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN et al (2004) A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431(7004):84–87
Hanekom M, Van der Spuy GD, Streicher E, Ndabambi SL, McEvoy CRE, Kidd M et al (2007) A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol 45(5):1483–1490
Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D et al (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685):537–544
Smith NH, Kremer K, Inwald J, Dale J, Driscoll JR, Gordon SV et al (2006) Ecotypes of the Mycobacterium tuberculosis complex. J Theor Biol 239(2):220–225
Comas I, Homolka S, Niemann S, Gagneux S (2009) Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS ONE 4(11):e7815
Comas I, Gagneux S (2009) The past and future of tuberculosis research. PLoS Pathog 5(10):e1000600
Van Belkum A (2003) High-throughput epidemiologic typing in clinical microbiology. Clin Microbiol Infect 9(2):86–100
Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes S, Willery E et al (2006) Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 44(12):4498–4510
Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K et al (2002) A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A 99(6):3684–3689
Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS et al (1997) Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A 94(18):9869–9874
Gagneux S (2012) Host-pathogen coevolution in human tuberculosis. Philos Trans R Soc Lond B Biol Sci 367(1590):850–859
Fabre M, Hauck Y, Soler C, Koeck J-L, Van Ingen J, Van Soolingen D et al (2010) Molecular characteristics of “Mycobacterium canettii” the smooth Mycobacterium tuberculosis bacilli. Infect Genet Evol 10(8):1165–1173
Huard RC, Fabre M, De Haas P, Claudio Oliveira Lazzarini L, Van Soolingen D, Cousins D et al (2006) Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex. J Bacteriol 188(12):4271–4287
Alexander KA, Laver PN, Michel AL, Williams M, Van Helden PD, Warren RM et al (2010) Novel Mycobacterium tuberculosis complex pathogen, M. mungi. Emerg Infect Dis 16(8):1296–1299
Bentley SD, Comas I, Bryant JM, Walker D, Smith NH, Harris SR et al (2012) The genome of Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome erosion common to the M. tuberculosis complex. PLoS Negl Trop Dis 6(2):e1552
Achtman M (2008) Evolution, population structure, and phylogeography of genetically monomorphic bacterial pathogens. Annu Rev Microbiol 62:53–70
Weniger T, Krawczyk J, Supply P, Harmsen D, Niemann S (2012) Online tools for polyphasic analysis of Mycobacterium tuberculosis complex genotyping data: now and next. Infect Genet Evol 12(4):748–754
Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, Homolka S et al (2008) High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 6(12):e311
Kato-Maeda M, Metcalfe JZ, Flores L (2011) Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies. Future Microbiol 6(2):203–216
Van Soolingen D, Kremer K (2009) [Findings and ongoing research in the molecular epidemiology of tuberculosis]. Kekkaku 84(2):83–89
Schürch AC, Van Soolingen D (2011) DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencing. Infect Genet Evol. http://www.ncbi.nlm.nih.gov/pubmed/22067515. Accessed 20 Feb 2012
Burgos MV, Pym AS (2002) Molecular epidemiology of tuberculosis. Eur Respir J 20(36 suppl):54s–65s
Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN (2006) Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 19(4):658–685
Fok A, Numata Y, Schulzer M, FitzGerald MJ (2008) Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies. Int J Tuberc Lung Dis 12(5):480–492
van Soolingen D, Borgdorff MW, de Haas PEW, Sebek MMGG, Veen J, Dessens M et al (1999) Molecular epidemiology of tuberculosis in the Netherlands: A nationwide study from 1993 through 1997. J Infect Dis 180(3):726–736
Bifani PJ (1996) Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275(6):452–457
Glynn JR, Whiteley J, Bifani PJ, Kremer K, Van Soolingen D (2002) Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 8(8):843
Filliol I, Motiwala AS, Cavatore M, Qi W, Hazbón MH, Bobadilla del Valle M et al (2006) Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 188(2):759
Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM (2004) Stable association between strains of Mycobacterium tuberculosis and their human host populations. PNAS 101(14):4871–4876
Van Soolingen D, De Haas PE, Hermans PW, Groenen PM, Van Embden JD (1993) Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol 31(8):1987–1995
Van Embden JD, Van Soolingen D, Small PM, Hermans PW (1992) Genetic markers for the epidemiology of tuberculosis. Res Microbiol 143(4):385–391
Kremer K, Van Soolingen D, Frothingham R, Haas WH, Hermans PW, Martín C et al (1999) Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 37(8):2607–2618
Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC et al (1994) The epidemiology of tuberculosis in San Francisco–a population-based study using conventional and molecular methods. N Engl J Med 330(24):1703–1709
Caminero JA, Pena MJ, Campos-Herrero MI, Rodríguez JC, García I, Cabrera P et al (2001) Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med 164(7):1165–1170
de Beer JL, Kremer K, Ködmön C, Supply P, van Soolingen D (2012) First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strains. J Clin Microbiol 50(3):662–669
Van Soolingen D (2001) Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Intern Med 249(1):1–26
Kamerbeek J, Schouls L, Kolk A, Van Agterveld M, Van Soolingen D, Kuijper S et al (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35(4):907–914
Goguet de la Salmonière YO, Li HM, Torrea G, Bunschoten A, Van Embden J, Gicquel B (1997) Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis. J Clin Microbiol 35(9):2210–2214
Molhuizen HO, Bunschoten AE, Schouls LM, Van Embden JD (1998) Rapid detection and simultaneous strain differentiation of Mycobacterium tuberculosis complex bacteria by spoligotyping. Methods Mol Biol 101:381–394
Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA et al (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6:23
Tsolaki AG, Gagneux S, Pym AS, Goguet de la Salmoniere Y-OL, Kreiswirth BN, Van Soolingen D et al (2005) Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol 43(7):3185–3191
Skuce RA, McCorry TP, McCarroll JF, Roring SMM, Scott AN, Brittain D et al (2002) Discrimination of Mycobacterium tuberculosis complex bacteria using novel VNTR-PCR targets. Microbiology 148(Pt 2):519–528
Allix-Béguec C, Harmsen D, Weniger T, Supply P, Niemann S (2008) Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 46(8):2692–2699
Mazars E, Lesjean S, Banuls AL, Gilbert M, Vincent V, Gicquel B et al (2001) High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci 98(4):1901
Supply P, Lesjean S, Savine E, Kremer K, Van Soolingen D, Locht C (2001) Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol 39(10):3563–3571
Tsolaki AG, Hirsh AE, DeRiemer K, Enciso JA, Wong MZ, Hannan M et al (2004) Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. PNAS 101(14):4865–4870
Gutacker MM, Smoot JC, Migliaccio CAL, Ricklefs SM, Hua S, Cousins DV et al (2002) Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial STRAINS. Genetics 162(4):1533–1543
Supply P, Warren RM, Bañuls A-L, Lesjean S, Van Der Spuy GD, Lewis L-A et al (2003) Linkage disequilibrium between minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high tuberculosis incidence area. Mol Microbiol 47(2):529–538
Schürch AC, Van Soolingen D (2012) DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencing. Infect Genet Evol 12(4):602–609
Alland D, Whittam TS, Murray MB, Cave MD, Hazbon MH, Dix K et al (2003) Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis. J Bacteriol 185(11):3392
Ford C, Yusim K, Ioerger T, Feng S, Chase M, Greene M et al (2012) Mycobacterium tuberculosis–heterogeneity revealed through whole genome sequencing. Tuberculosis (Edinb) 92(3):194–201
Niemann S, Köser CU, Gagneux S, Plinke C, Homolka S, Bignell H et al (2009) Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints. PLoS ONE 4(10):e7407
Saunders NJ, Trivedi UH, Thomson ML, Doig C, Laurenson IF, Blaxter ML (2011) Deep resequencing of serial sputum isolates of Mycobacterium tuberculosis during therapeutic failure due to poor compliance reveals stepwise mutation of key resistance genes on an otherwise stable genetic background. J Infect 62(3):212–217
Boshoff HIM, Reed MB, Barry CE III, Mizrahi V (2003) DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113(2):183–193
Dos Vultos T, Mestre O, Tonjum T, Gicquel B (2009) DNA repair in Mycobacterium tuberculosis revisited. FEMS Microbiol Rev 33(3):471–487
Gardy JL, Johnston JC, Sui SJH, Cook VJ, Shah L, Brodkin E et al (2011) Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 364(8):730–739
Chen Y-Y, Chang J-R, Huang W-F, Kuo S-C, Su I-J, Sun J-R et al (2012) Genetic diversity of the Mycobacterium tuberculosis Beijing family based on SNP and VNTR typing profiles in Asian countries. PLoS ONE 7(7):e39792
van Deutekom H, Gerritsen JJJ, van Soolingen D, van Ameijden EJC, van Embden JDA, Coutinho RA (1997) A molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam. Clin Infect Dis 25(5):1071–1077
Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR Jr et al (1992) An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 326(4):231–235
Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR et al (1999) A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991–1997. Ann Intern Med 130(12):971–978
Goebel T (2007) The missing years for modern humans. Science 315(5809):194–196
Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M et al. (2005) Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog 1(1). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1238740/. Accessed 24 Sep 2012
Kappelman J, Alçiçek MC, Kazanci N, Schultz M, Ozkul M, Sen S (2008) First Homo erectus from Turkey and implications for migrations into temperate Eurasia. Am J Phys Anthropol 135(1):110–116
Barnes E (2007) Diseases and human evolution. UNM Press, New Mexico
Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P et al (2007) An African origin for the intimate association between humans and Helicobacter pylori. Nature 445(7130):915–918
Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S et al (2006) Variable host–pathogen compatibility in Mycobacterium tuberculosis. PNAS 103(8):2869–2873
Hewinson RG, Vordermeier HM, Smith NH, Gordon SV (2006) Recent advances in our knowledge of Mycobacterium bovis: a feeling for the organism. Vet Microbiol 112(2–4):127–139
Mostowy S, Inwald J, Gordon S, Martin C, Warren R, Kremer K et al (2005) Revisiting the evolution of Mycobacterium bovis. J Bacteriol 187(18):6386–6395
Garnier T, Eiglmeier K, Camus J-C, Medina N, Mansoor H, Pryor M et al (2003) The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A 100(13):7877–7882
Brosch R, Pym AS, Gordon SV, Cole ST (2001) The evolution of mycobacterial pathogenicity: clues from comparative genomics. Trends Microbiol 9(9):452–458
Djelouadji Z, Raoult D, Drancourt M (2011) Palaeogenomics of Mycobacterium tuberculosis: epidemic bursts with a degrading genome. Lancet Infect Dis 11(8):641–650
Smith NH (2012) The global distribution and phylogeography of Mycobacterium bovis clonal complexes. Infect Genet Evol 12(4):857–865
Gagneux S, Small PM (2007) Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 7(5):328–337
Gutacker MM, Mathema B, Soini H, Shashkina E, Kreiswirth BN, Graviss EA et al (2006) Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J Infect Dis 193(1):121–128
Wirth T, Hildebrand F, Allix-Béguec C, Wölbeling F, Kubica T, Kremer K et al (2008) Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog 4(9):e1000160
Coscolla M, Gagneux S (2010) Does M. tuberculosis genomic diversity explain disease diversity? Drug Discov Today Dis Mech 7(1):e43–e59
Reed MB, Gagneux S, Deriemer K, Small PM, Barry CE (2007) The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol 189(7):2583–2589
Comas I, Gagneux S (2011) A role for systems epidemiology in tuberculosis research. Trends Microbiol 19(10):492–500
Portevin D, Gagneux S, Comas I, Young D (2011) Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog 7(3):e1001307
De Jong BC, Hill PC, Aiken A, Awine T, Antonio M, Adetifa IM et al (2008) Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 198(7):1037–1043
Van Soolingen D, Qian L, De Haas PE, Douglas JT, Traore H, Portaels F et al (1995) Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 33(12):3234–3238
Anh DD, Borgdorff MW, Van LN, Lan NT, Van Gorkom T, Kremer K et al (2000) Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 6(3):302–305
Chan MY, Borgdorff M, Yip CW, De Haas PEW, Wong WS, Kam KM et al. (2001) Seventy percent of the Mycobacterium tuberculosis isolates in Hong Kong represent the Beijing genotype. Epidemiol Infect 127(01). http://www.journals.cambridge.org/abstract_S0950268801005659. Accessed 30 Oct 2012
Mokrousov I (2008) Genetic geography of Mycobacterium tuberculosis Beijing genotype: a multifacet mirror of human history? Infect Genet Evol 8(6):777–785
Cowley D, Govender D, February B, Wolfe M, Steyn L, Evans J et al (2008) Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis 47(10):1252–1259
Parwati I, Van Crevel R, Van Soolingen D (2010) Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect Dis 10(2):103–111
Schürch AC, Kremer K, Hendriks ACA, Freyee B, McEvoy CRE, Van Crevel R et al (2011) SNP/RD typing of Mycobacterium tuberculosis Beijing strains reveals local and worldwide disseminated clonal complexes. PLoS ONE 6(12):e28365
Röltgen K, Qi W, Ruf M-T, Mensah-Quainoo E, Pidot SJ, Seemann T et al (2010) Single nucleotide polymorphism typing of Mycobacterium ulcerans reveals focal transmission of buruli ulcer in a highly endemic region of Ghana. PLoS Negl Trop Dis 4(7):e751
Morelli G, Song Y, Mazzoni CJ, Eppinger M, Roumagnac P, Wagner DM et al (2010) Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet 42(12):1140–1143
Monot M, Honoré N, Garnier T, Zidane N, Sherafi D, Paniz-Mondolfi A et al (2009) Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet 41(12):1282–1289
De Jong BC, Antonio M, Gagneux S (2010) Mycobacterium africanum–review of an important cause of human tuberculosis in West Africa. PLoS Negl Trop Dis 4(9):e744
Mostowy S, Cousins D, Brinkman J, Aranaz A, Behr MA (2002) Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J Infect Dis 186(1):74–80
Intemann CD, Thye T, Niemann S, Browne ENL, Amanua Chinbuah M, Enimil A et al. (2009) Autophagy gene variant IRGM − 261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains. PLoS Pathog 5(9). http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735778/. Accessed 17 Oct 2012
Jamison DTDT, Breman JGJG, Measham ARAR, Alleyne GG, Claeson MM, Evans DBDB et al (eds) (2006) Disease control priorities in developing countries, 2nd edn. World Bank, Washington (DC)
Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, ZiaZarifi AH et al (2009) Emergence of new forms of totally drug-resistant tuberculosis bacilli super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest 136(2):420–425
Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C (2012) Totally drug-resistant tuberculosis in India. Clin Infect Dis 54(4):579–581
Burgos M, Gonzalez LC, Paz EA, Gournis E, Kawamura LM, Schecter G et al (2005) Treatment of multidrug-resistant tuberculosis in San Francisco: an outpatient-based approach. Clin Infect Dis 40(7):968–975
Zignol M, van Gemert W, Falzon D, Sismanidis C, Glaziou P, Floyd K, Raviglione M (2012) Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010. Bull WHO 90:111
Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F et al (1998) Global surveillance for antituberculosis-drug resistance, 1994–1997. N Engl J Med 338(23):1641–1649
Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U et al (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368(9547):1575–1580
Dalton T, Cegielski P, Akksilp S, Asencios L, Caoili JC, Cho S-N et al (2012) Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet;380(9851):1406–17
Shah NPR (2008) Extensively drug-resistant tuberculosis in the united states, 1993–2007. JAMA 300(18):2153–2160
McIlleron H, Rustomjee R, Vahedi M, Mthiyane T, Denti P, Connolly C et al (2012) Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines. Antimicrob Agents Chemother 56(6):3232–3238
Mukinda FK, Theron D, Van der Spuy GD, Jacobson KR, Roscher M, Streicher EM et al (2012) Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa. Int J Tuberc Lung Dis 16(2):196–202
WHO (2010) Multidrug and extensively drug-resistant TB (M/XDR-TB). World Health Organization, Geneva
WHO (2012) Surveillance of drug resistance in tuberculosis. WHO. http://www.who.int/tb/publications/mdr_surveillance/en/index.html. Accessed 21 Dec 2012
Gandhi NR, Weissman D, Moodley P, Ramathal M, Elson I, Kreiswirth BN et al (2013) Nosocomial transmission of extensively drug-resistant tuberculosis in a rural hospital in South Africa. J Infect Dis 207(1):9–17
Ioerger TR, Koo S, No E-G, Chen X, Larsen MH, Jacobs WR et al (2009) Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa. PLoS ONE 4(11):e7778
McElroy PD, Sterling TR, Driver CR, Kreiswirth B, Woodley CL, Cronin WA et al (2002) Use of DNA fingerprinting to investigate a multiyear, multistate tuberculosis outbreak. Emerg Infect Dis 8(11):1252–1256
Moss AR, Alland D, Telzak E, Hewlett D Jr, Sharp V, Chiliade P et al (1997) A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int J Tuberc Lung Dis 1(2):115–121
Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B et al (1996) A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 276(15):1229–1235
Frieden TR, Fujiwara PI, Washko RM, Hamburg MA (1995) Tuberculosis in New York City–turning the tide. N Engl J Med 333(4):229–233
Stroud LA, Tokars JI, Grieco MH, Crawford JT, Culver DH, Edlin BR et al (1995) Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol 16(3):141–147
Lawn SD, Wood R, De Cock KM, Kranzer K, Lewis JJ, Churchyard GJ (2010) Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis 10(7):489–498
Akolo C, Adetifa I, Shepperd S, Volmink J (2010) Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev (1):CD000171
Borrell S, Gagneux S (2009) Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 13(12):1456–1466
Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC (2005) Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293(22):2767
Dye C, Williams BG (2010) The population dynamics and control of tuberculosis. Science 328(5980):856–861
Dye C, Williams BG, Espinal MA, Raviglione MC (2002) Erasing the world’s slow stain: strategies to beat multidrug-resistant tuberculosis. Science 295(5562):2042–2046
Cohen T, Murray M (2004) Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat Med 10(10):1117–1121
Borrell S, Gagneux S (2011) Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis. Clin Microbiol Infect 17(6):815–820
Gagneux S, Burgos MV, DeRiemer K, Encisco A, Muñoz S, Hopewell PC et al (2006) Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog 2(6):e61
Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-Maeda M et al (2011) Whole-genome sequencing of rifampicin-resistant M. tuberculosis strains identifies compensatory mutations in RNA polymerase. Nat Genet 44(1):106–110
Zhang Y, Heym B, Allen B, Young D, Cole S (1992) The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358(6387):591–593
Timmins GS, Deretic V (2006) Mechanisms of action of isoniazid. Mol Microbiol 62(5):1220–1227
Maisnier-Patin S, Andersson DI (2004) Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res Microbiol 155(5):360–369
Sherman DR, Mdluli K, Hickey MJ, Arain TM, Morris SL, Barry CE III et al (1996) Compensatory ahpC Gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272(5268):1641–1643
Rouse DA, DeVito JA, Li Z, Byer H, Morris SL (1996) Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis-, effects on catalase- peroxidase activities and isoniazid resistance. Mol Microbiol 22(3):583–592
Pym AS, Domenech P, Honoré N, Song J, Deretic V, Cole ST (2001) Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. Mol Microbiol 40(4):879–889
Wilson T, de Lisle GW, Marcinkeviciene JA, Blanchardand JS, Collins DM (1998) Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties. Microbiology 144(10):2687–2695
Heym B, Stavropoulos E, Honoré N, Domenech P, Saint-Joanis B, Wilson TM et al (1997) Effects of over expression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infect Immun 65(4):1395–1401
Gagneux S, Long CD, Small PM, Van T, Schoolnik GK, Bohannan BJM (2006) The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312(5782):1944–1946
Brandis G, Wrande M, Liljas L, Hughes D (2012) Fitness-compensatory mutations in rifampicin-resistant RNA polymerase. Mol Microbiol 85(1):142–151
De Vos M, Muller B, Borrell S et al (2012) Putative compensatory mutations in the rpoC gene of rifampin-resistant mycobacterium tuberculosis are associated with ongoing transmission. Antimicrob Age Chemother 57(2):827–832. doi:10.1128/AAC.01541-12
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Burgos, M. (2013). Mycobacterium tuberculosis: Evolution, Host–Pathogen Interactions, and Implications for Tuberculosis Control. In: Sree Hari Rao, V., Durvasula, R. (eds) Dynamic Models of Infectious Diseases. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9224-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9224-5_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9223-8
Online ISBN: 978-1-4614-9224-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)